Virtu Financial LLC Red Hill Biopharma Ltd. Transaction History

Virtu Financial LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.5 - $523.8 $9,621 - $10.1 Million	19,242 Added 44.81%	62,182 $31,000
Q2 2022 Aug 09, 2022	BUY	$0.63 - $2.58 $10,127 - $41,476	16,076 Added 59.84%	42,940 $37,000
Q1 2022 May 17, 2022	BUY	$1.65 - $3.12 $44,325 - $83,815	26,864 New	26,864 $68,000
Q4 2021 Feb 17, 2022	SELL	$2.31 - $5.85 $44,391 - $112,419	-19,217 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$4.55 - $10.36 $87,437 - $199,088	19,217 New	19,217 $88,000
Q1 2021 May 19, 2021	SELL	$6.98 - $11.29 $210,705 - $340,811	-30,187 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$7.81 - $10.39 $97,546 - $129,771	12,490 Added 70.58%	30,187 $244,000
Q3 2020 Dec 11, 2020	BUY	$6.34 - $10.83 $112,198 - $191,658	17,697 New	17,697 $181,000
Q2 2020 Aug 07, 2020	SELL	$4.6 - $8.6 $46,634 - $87,186	-10,138 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$5.76 - $7.35 $58,394 - $74,514	10,138 New	10,138 $62,000
Q3 2019 Nov 20, 2019	SELL	$6.46 - $8.37 $71,344 - $92,438	-11,044 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$6.34 - $8.8 $70,018 - $97,187	11,044 New	11,044 $72,000
Q1 2018 May 14, 2018	SELL	$4.96 - $6.84 $301,503 - $415,783	-60,787 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$4.58 - $10.81 $278,404 - $657,107	60,787	60,787 $312,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.